https://specialty.mims.com/topic/lower-all-cause-death--fewer-hf-events-with-empagliflozin-in-acute-hf
Patients hospitalized with acute heart failure (HF) have a reduced risk of subsequent HF events or all-cause mortality if treated with once-daily empa...
Create an account or login to join the discussion